Alternative Pathway Inhibition Makes Good in IgA Nephropathy

(MedPage Today) -- SAN DIEGO--There was a clinically meaningful reduction in proteinuria with iptacopan (Fabhalta), and a confirmed clinical benefit of alternative pathway inhibition, in a rare kidney disorder, according to an interim analysis...